Omega-3 is good for the environment your nerves live in. The direct evidence that it repairs damaged nerves is limited and mixed. A 2025 Cochrane review of omega-3 for diabetic peripheral neuropathy found only two randomized trials with 87 participants between them and concluded the evidence was insufficient to draw conclusions. One of those trials did show structural regeneration of small nerve fibers over six months. The much larger and better established evidence is that omega-3 lowers inflammatory markers, helps in several chronic pain conditions, lowers triglycerides and tracks with lower

Fish oil supports the tissue environment nerves depend on. Peripheral nerve membranes are roughly 70 to 80 percent lipid by dry weight, DHA is a structural component of that membrane, and nerve regeneration depends on an inflammatory response that starts, does its job and then resolves. Omega-3 fatty acids influence all of those. What has not been demonstrated in a convincing human trial is that supplementing fish oil restores nerve function once nerves are already damaged.

No. Omega-3 is not a NeuroAxis ingredient, and this article is not a product pitch for it. Omega-3 is a dietary recommendation. NeuroAxis is built around targeted nerve nutrients such as methylcobalamin, benfotiamine, alpha-lipoic acid and acetyl-L-carnitine, which address the myelin, metabolic and oxidative pathways that dietary fat does not touch. They are complementary rather than interchangeable, and neither one substitutes for a proper diagnosis.